Christianne J. Buskens
University of Amsterdam
230 Papers
707 Citations
Christianne J. Buskens is an academic researcher from University of Amsterdam. The author has contributed to research in topics: Medicine & Crohn's disease. The author has an hindex of 37, co-authored 190 publications. Previous affiliations of Christianne J. Buskens include Academic Medical Center & John Radcliffe Hospital.
Chat about Author
Papers
Systematic Review of Sentinel Lymph Node Mapping Procedure in Colorectal Cancer
Edwin S. van der Zaag,Wim H. Bouma,Pieter J. Tanis,Dirk T. Ubbink,Willem A. Bemelman,Christianne J. Buskens +5 more
TL;DR: The ex vivo SN mapping is an easy technique it should be considered in addition to conventional resection in colon cancer and has an overall sensitivity of 70 %, with increased sensitivity and refined staging in early-stage colon cancer.
98
Completion surgery following transanal endoscopic microsurgery: assessment of quality and short- and long-term outcome.
Roel Hompes,R. McDonald,Christianne J. Buskens,Ian Lindsey,N. C. Armitage,Jane E. Hill,A. N. D. Scott,Neil Mortensen,Chris Cunningham +8 more
TL;DR: Patients with unfavourable pathology after transanal endoscopic microsurgery (TEM) should be offered completion surgery (CS) if appropriate and factors compromising the quality of resection specimens are identified.
97
The prognostic value of micrometastases and isolated tumour cells in histologically negative lymph nodes of patients with colorectal cancer: a systematic review and meta-analysis.
D.A.M. Sloothaak,Saloomeh Sahami,H.J. van der Zaag-Loonen,E.S. van der Zaag,Pieter J. Tanis,W. A. Bemelman,Christianne J. Buskens +6 more
TL;DR: Patients with stage I/II colorectal cancer and MMs have a worse prognosis than patients without occult tumour cells, however, ITCs do not have a predictive value.
93
Benign tracheo-neo-esophageal fistulas after subtotal esophagectomy.
TL;DR: A benign tracheo-neo-esophageal fistula after esophagectomy is a rare, but serious complication and site and size of the fistula, together with the severity of symptoms, should dictate management.
92
Treatment of Perianal Fistulas in Crohn’s Disease, Seton Versus Anti-TNF Versus Surgical Closure Following Anti-TNF [PISA]: A Randomised Controlled Trial
Karin A. T. G. M. Wasmann,E. Joline de Groof,Merel E. Stellingwerf,Geert R. D'Haens,Cyriel Y. Ponsioen,Krisztina B Gecse,Marcel G. W. Dijkgraaf,Michael F. Gerhards,Jeroen M. Jansen,Apollo Pronk,Sebastiaan A.C. van Tuyl,David D. E. Zimmerman,Karlien F. Bruin,Antonino Spinelli,Silvio Danese,Jarmila D. W. van der Bilt,M.W. Mundt,Willem A Bemelman,Christianne J. Buskens +18 more
TL;DR: The results imply that chronic seton treatment should not be recommended as the sole treatment for perianal Crohn’s fistulas, and interestingly, in the PISA prospective registry, inferiority of chronic set on treatment was not observed for any outcome measure.